Defiance Daily Target 2X Long NVO ETF (NYSEARCA:NVOX – Get Free Report) was the recipient of a significant decline in short interest in October. As of October 15th, there was short interest totaling 187,173 shares, a decline of 70.0% from the September 30th total of 624,282 shares. Based on an average trading volume of 514,682 shares, the short-interest ratio is currently 0.4 days. Currently, 4.7% of the company’s shares are short sold.
Defiance Daily Target 2X Long NVO ETF Price Performance
NYSEARCA:NVOX opened at $9.65 on Wednesday. Defiance Daily Target 2X Long NVO ETF has a 1 year low of $8.87 and a 1 year high of $33.81. The stock has a 50-day moving average price of $11.59 and a two-hundred day moving average price of $14.70.
Defiance Daily Target 2X Long NVO ETF Company Profile
The Defiance Daily Target 2X Long NVO ETF (NVOX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of NOVO Nordisk A/S – ADR (NVO), less fees and expenses, through derivatives like swap agreements. NVOX was launched on Dec 2, 2024 and is issued by Defiance.
Featured Articles
- Five stocks we like better than Defiance Daily Target 2X Long NVO ETF
- Hidden in Plain Sight: 2 Earnings Winners Investors May Have Missed
- These 3 New ETFs Are Turning Heads—Are They Worth Buying?
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
Receive News & Ratings for Defiance Daily Target 2X Long NVO ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Defiance Daily Target 2X Long NVO ETF and related companies with MarketBeat.com's FREE daily email newsletter.
